Q1: I just read the "prescribing information " for my new daily Valtrex scrip. The way I read it, 1.9 % of Valtrex test group acquired HSV2, while 3.6% percent of the placebo group acquired. Doesn't that mean that almost all of the prevention of acquistion (i.e. 96.4 %) came from the recommended condom or some form of immunity? The drug rep, er, I mean the physician's assistant, who pre$cribed Valtrex, didn't tell me that part !!! Am I interpreting this right?
Q2: Lacking a condom for my lips, is there any data on Valtrex reduction of transmission of HSV from lip tissue that is clear of lesions? Or is that an issue? Not contained in "prescribing information." Is it reasonable to assume a big reduction from Valtrex?